{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:00:38Z","timestamp":1760853638814},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":9502,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1994]]},"DOI":"10.1093\/annonc\/5.suppl_1.s25","type":"journal-article","created":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T21:54:43Z","timestamp":1353362083000},"page":"S25-S30","source":"Crossref","is-referenced-by-count":64,"special_numbering":"S1","title":["Primary Ki-1-positive anaplastic large-cell lymphoma: A distinct clinicopathologic entity"],"prefix":"10.1016","volume":"5","author":[{"given":"M.E.","family":"Kadin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/299065a0","article-title":"Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin\u2019s disease and a subset of normal lymphoid cells","volume":"299","author":"Schwab","year":"1982","journal-title":"Nature"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0065","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.bloodjournal664848","article-title":"The expression of the Hodgkin\u2019s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein","year":"1985","journal-title":"Blood"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0070","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1182\/blood.V68.5.1042.1042","article-title":"Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy","volume":"68","author":"Kadin","year":"1986","journal-title":"Blood"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0075","first-page":"59","article-title":"Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large-cell lymphomas. Diagnostic value in socalled malignant histiocytosis","volume":"130","author":"Delsol","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0080","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1200\/JCO.1991.9.4.539","article-title":"Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma","volume":"9","author":"Greer","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0085","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/1097-0142(19910701)68:1<118::AID-CNCR2820680123>3.0.CO;2-R","article-title":"Clinicopathologic study of large-cell anaplastic lymphoma (Ki-1-positive large-cell lymphoma) among the Japanese","volume":"68","author":"Nakamura","year":"1991","journal-title":"Cancer"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0090","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1200\/JCO.1993.11.5.937","article-title":"Primary anaplastic large-cell lymphoma in adults: Clinical characteristics and therapeutic outcome","volume":"11","author":"Shulman","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0095","series-title":"Histopathology of Non-Hodgkin\u2019s lymphomas (based on the updated Kiel classification)","first-page":"165","author":"Lennert","year":"1992"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0100","first-page":"1189","article-title":"Epidemiology of Hodgkin\u2019s disease","volume":"26","author":"MacMahon","year":"1966","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0105","first-page":"359","article-title":"Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large-cell lymphomas. Morphologic, immunohistologic, and clinical characteristics","volume":"135","author":"Kaudewitz","year":"1989","journal-title":"Cancer"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0110","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/1097-0142(19930315)71:6<2062::AID-CNCR2820710622>3.0.CO;2-0","article-title":"Patterns of presentation of Hodgkin\u2019s disease: Implications for etiology and pathogenesis","volume":"71","author":"Mauch","year":"1993","journal-title":"Cancer"},{"issue":"1","key":"10.1093\/annonc\/5.suppl_1.S25_bb0115","first-page":"121a","article-title":"Lack of prognostic significance of Ki-1 (CD30) positivity in disseminated pediatric large-cell lymphoma","volume":"78","author":"Kadin","year":"1991","journal-title":"Blood"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0120","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00000478-199005000-00003","article-title":"Ki-1-positive large-cell lymphoma: A clinicopathologic study of 41 cases","volume":"41","author":"Chott","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0125","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/1097-0142(19911115)68:10<2186::AID-CNCR2820681017>3.0.CO;2-D","article-title":"Anaplastic large-cell Ki-1 lymphoma of bone","volume":"68","author":"Chan","year":"1991","journal-title":"Cancer"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0130","first-page":"1169","article-title":"Prognostic significance of CD30 (Ki-1\/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin: A clinicopathologic and immunohistochemical study in 20 patients","volume":"135","author":"Belgaards","year":"1989","journal-title":"Cancer"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0135","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/1097-0142(19910115)67:2<516::AID-CNCR2820670233>3.0.CO;2-J","article-title":"Long-term survival in Ki-1 lymphoma","volume":"67","author":"Salhany","year":"1991","journal-title":"Cancer"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0140","series-title":"Proc Am Soc Clin Oncol","article-title":"Primary Ki-1+ lymphoma: Clinicopathologic features of 58 patients","author":"Greer","year":"1993"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0145","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.1990.8.4.657","article-title":"Bone marrow transplantation for childhood Ki-1 lymphoma","volume":"8","author":"Chakravarti","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0150","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00000478-198804000-00002","article-title":"Ki-1-positive large-cell lymphoma: A morphologic and immunologic study of 19 cases","volume":"12","author":"Agnarsson","year":"1988","journal-title":"Am J Surg Path"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0155","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2559.1990.tb01143.x","article-title":"Lymphohistiocytic T-cell lymphoma (anaplastic large-cell lymphoma CD30+\/Ki-1+ with a high content of reactive histiocytes)","volume":"16","author":"Pileri","year":"1990","journal-title":"Histopathology"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2559.1989.tb03038.x","article-title":"Anaplastic large-cell Ki-1 lymphoma: Delineation of two morphological types","volume":"15","author":"Chan","year":"1989","journal-title":"Histopathology"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0165","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/00000478-199010000-00013","article-title":"Sarcomatoid variant of anaplastic large-cell Ki-1 lymphoma","volume":"14","author":"Chan","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0170","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00000478-199309000-00001","article-title":"A small-cell variant of primary Ki-1 (CD30)+ T-cell lymphoma","volume":"17","author":"Kinney","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0175","first-page":"354a","article-title":"Childhood Ki-1+ anaplastic large-cell lymphoma: Establishment and characterization of a new tumor cell line transplantable to SCID mice","volume":"76","author":"Kadin","year":"1990","journal-title":"Blood"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0180","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/bjc.1991.299","article-title":"Antibody BNH9 detects red blood cell-related antigens on anaplastic large-cell (CD30+) lymphomas","volume":"64","author":"Delsol","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0185","first-page":"446","article-title":"Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma","volume":"133","author":"Pallesen","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0190","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1182\/blood.V74.5.1678.1678","article-title":"BER-H2: A new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope","volume":"74","author":"Schwarting","year":"1989","journal-title":"Blood"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0195","first-page":"1413","article-title":"Cytokeratin expression and vimentin content in large-cell anaplastic lymphomas and other non-Hodgkin\u2019s lymphomas","volume":"138","author":"Gustman","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0200","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0046-8177(96)90009-X","article-title":"Variable expression of leucocyte-common (CD45) antigen in CD30 (Ki-1)-positive anaplastic large-cell lymphoma: Implications for the differential diagnosis between lymphoid and nonlymphoid malignancies","volume":"21","author":"Falini","year":"1990","journal-title":"Human Pathol"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0205","first-page":"1192","article-title":"CD30-positive anaplastic large-cell lymphomas that express CD15 but lack CD45: A possible diagnostic pitfall","volume":"116","author":"Perkins","year":"1992","journal-title":"Arch Pathol"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0210","first-page":"316","article-title":"Morphologic and immunologic characteristics of 50 peripheral T-cell lymphomas","volume":"118","author":"Weiss","year":"1985","journal-title":"Am J Pathol"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0215","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2559.1987.tb02687.x","article-title":"Genotypic analysis of large-cell lymphoma which express the Ki-1 antigen","volume":"11","author":"O\u2019Connor","year":"1987","journal-title":"Histopathology"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0220","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0145-2126(89)90134-3","article-title":"Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin\u2019s disease and Ki-1-positive anaplastic large-cell lymphoma: Dissociation between phenotype and genotype","volume":"13","author":"Herbst","year":"1989","journal-title":"Leuk Res"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0225","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1182\/blood.V72.1.234.234","article-title":"A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin\u2019s lymphoma, showing a 2; 5 translocation and rearrangement of the T-cell receptor B-chain gene","volume":"72","author":"Fischer","year":"1988","journal-title":"Blood"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0230","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2141.1989.tb06270.x","article-title":"A translocation involving a specific breakpoint on chromosome 5 is characteristic of anaplastic large-cell lymphoma (\u2018Ki-1 lymphoma\u2019)","volume":"71","author":"Rimokh","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0235","first-page":"866","article-title":"The t(2; 5) (p23; q35): A recurring chromosomal abnormality in Ki-1-positive anaplastic large-cell lymphoma","volume":"3","author":"Le Beau","year":"1989","journal-title":"Leukemia"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0240","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/gcc.2870020106","article-title":"Immunohistochemical, molecular, and cytogenetic analysis of a consecutive series of 20 peripheral T-cell lymphomas and lymphomas of uncertain lineage, including 12 Ki-1-positive lymphomas","volume":"2","author":"Ebrahim","year":"1990","journal-title":"Genes, Chromosomes & Cancer"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0245","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.2910450329","article-title":"DEL cell line: A \u2018malignant histiocytosis\u2019 CD30+ t(5; 6) (q35; p21) cell line","volume":"45","author":"Barbey","year":"1990","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0250","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2141.1990.tb07812.x","article-title":"A novel variant translocation t(2; 13) (p23; q34) in Ki-1 large-cell anaplastic lymphoma","volume":"75","author":"Sainati","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0255","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1073\/pnas.87.2.628","article-title":"Molecular analysis of a chromosomal translocation, t(9; 14) (pl3; q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen","volume":"87","author":"Ohno","year":"1990","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0260","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1182\/blood.V73.8.2155.2155","article-title":"Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2; 5) (p23; q35) common to malignancies with features of so-called malignant histiocytosis","volume":"73","author":"Morgan","year":"1989","journal-title":"Blood"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0265","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00000478-199004000-00001","article-title":"Morphology in Ki-1 (CD30)-positive non-Hodgkin\u2019s lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2; 5) (p23; q35)","volume":"14","author":"Bitter","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0270","first-page":"625","article-title":"Ki-1 antigen expression defines a favorable clinical subset of non-B-cell non-Hodgkin\u2019s lymphoma","volume":"9","author":"Offit","year":"1990","journal-title":"Leukemia"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0275","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/1097-0142(19930101)71:1<257::AID-CNCR2820710139>3.0.CO;2-B","article-title":"Peripheral T-cell lymphoma in childhood and adolescence. A clinicopathologic study of 22 patients","volume":"71","author":"Gordon","year":"1993","journal-title":"Cancer"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0280","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: Clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0285","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM198308043090501","article-title":"Clinical course of retrovirus-associated adult T-cell lymphoma in the United States","volume":"309","author":"Bunn","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0290","first-page":"1317","article-title":"Detection of HTLV-1 proviral sequences in CD30-positive large-cell cutaneous T-cell lymphomas","volume":"137","author":"Anagnostopoulos","year":"1990","journal-title":"Am J Pathol"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0295","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0165-4608(81)90092-3","article-title":"Chromosome 14q+ in adult T-cell leukemia","volume":"3","author":"Miyoshi","year":"1981","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM197501022920101","article-title":"Immunoblastic lymphadenopathy: A hyperimmune entity resembling Hodgkin\u2019s disease","volume":"292","author":"Lukes","year":"1975","journal-title":"N Eng J Med"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0305","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0002-9343(75)90466-0","article-title":"Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course","volume":"59","author":"Frizerra","year":"1975","journal-title":"Am J Med"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0310","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0145-2126(87)90024-5","article-title":"Chromosomal abnormalities in lymphogranulomatosis X (Lgr X)\/angioimmuno-blastic lymphadenopathy (AILD)","volume":"11","author":"Godde-Salz","year":"1987","journal-title":"Leuk Res"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0315","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1182\/blood.V72.5.1674.1674","article-title":"Angiocentric immunoproliferative lesions: A clinicopathologic spectrum of post-thymic T-cell proliferations","volume":"72","author":"Lipford","year":"1988","journal-title":"Blood"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0320","first-page":"275","article-title":"Perivascular Ki-1+ lesions","volume":"55","author":"Sioutos","year":"1992","journal-title":"Internat J Hematol"},{"key":"10.1093\/annonc\/5.suppl_1.S25_bb0325","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/1523-1747.ep12497947","article-title":"Clonal characteristics of cutaneous T-cell lymphomas: Cytogenetic evidence from blood, lymph nodes, and skin","volume":"78","author":"Nowell","year":"1982","journal-title":"J Invest Dermat"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419633569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419633569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/5\/suppl_1\/S25\/6679267\/5-suppl_1-S25.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T10:14:23Z","timestamp":1589537663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419633569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"references-count":54,"alternative-id":["S0923753419633569"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/5.suppl_1.s25","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1994]]}}}